South KoreaStand No: 90G32
Ahn-Gook Pharmaceutical Co., Ltd. is a leading pharmaceutical company in Korea, we're especially strong to Repiratory system and Cardiovascular disease. Our product, Synatura Syrup is a new drug and No. 1 of antitussive products in Korea, we're already under registration over the 10 countries. We are accululating core technology to develop new world-class medicine and fostering key manpower that can develop and market our new products.
South KoreaStand No: 90G36
AK & MN BioFarm is the leading Omega-3 API Manufacturer in the world. All the products from AK & MN Biofarm are produced under GMP and HACCP guide line. Our own technologies and the most advanced facilities allow AK & MN BioFarm to offer customers various EPA and/or DHA products from low concentration to over 99% purest products. Upon the customer requests, all formulation of Omega-3 is available from Food supplements to Active Pharmaceutical Ingredients.
South KoreaStand No: 90G65
BCWORLD PHARM is a technology-driven pharmaceutical company in Korea whose expertise in formulation and process development enable it to provide quality generics. We strive to establish its position as a pioneer in developing innovative products through cutting-edge formulation technology including immediate/controlled release as well as fast-dissolving DDS, GRS and depot formulation. Recently, we not only have been certified as KIPC by Korea Ministry of Health & Welfare but also designated as ATC by Korea Ministry of Knowledge Economy. Now, we are constructing new EUGMP and cGMP facilities complied with EU/US guideline which is expected to be completed at the end of 2014.
South KoreaStand No: 90G30
BMI Korea aims to be a sophisticated bio-pharmaceutical company by integrating biotechnology and medicine. The representative product is Hirax, highly purified hyaluronidase, maximizes the dispersion and absorption of other injected drugs minimizing side effects caused by impurity proteins. We have also Hibarry, an anti-adhesion barrier gel certificated by CE.
South KoreaStand No: 90D43
BNC Korea Corp. has obtained various results from steady research and development since its establishment in 2007. NC Korea researches and develops strategic products which may lead the Bio-market in next generation: medical appliances, medical supplies and cosmeceutical products, processed based on hyaluronic acid and collagen. At the laboratory affiliated with the company developed a first hyaluronic acid filler in Korea after going through a research on a technology which can be applied to inside human body using biocompatible polymeric materials. Like our company's CI symbol, Biotechnology Next Challenge, we are giving our best effort to challenge and make a new leap forward to develop innovative products based on life science technology.
South KoreaStand No: 90G69
Boryung Pharmaceutical Company, aiming to be the best not the biggest, started since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies. Boryung has invested continually on research and development and made continuous efforts to produce high-quality products. Lately by developing new drug, Fimasartan (8th Angiotensin Receptor Blocker over the world) with its own R&D,Boryung is accelerating its R&D activity to become the global health care company. Boryung has continued to expand the global network and now, it's partners and markets cover Japan, China, ASEAN, Europe, Latin America, Middle East, and Africa.
South KoreaStand No: 90G67
Chemport Inc. was established in 2001 and has been a leading Omega-3 fatty acid manfuacturer with our own high technology. We are capable of producing up to 97% of EPA, 95% of DHA, and 95% of EPA & DHA blends omega-3 fish oil. We are one of the extremly few capable companines in the world which can supply two FDA approved prescribed fish oil drus, Omega-3 Acid Ethyl Esters called Lovaza and Omacor and EPA min. 96% called Vascepa along with high concentrated fish oil supplements.
South KoreaStand No: 90G55
CKD Bio Corporation CKD Bio is devoted to serving the better life through better medicines, with over 65-years experience in the pharmaceutical industry. CKD Bio manufactures the highest quality intermediates and APIs through fully integrated manufacturing process from fermentation to chemical synthesis. CKD Bio is specialized in Contract Manufacturing and Contract Research in the field of fermentation and chemical synthesis. CKD Bio is trying to open the next era by developing the latest and newest generation of pharmaceutical products such as antibiotics, anti-diabetics, anti-fungal and etc,.
South KoreaStand No: 90G60
CTCBIO is a Korean pharmaceutical company which holds the top 50 domestic pharmaceutical companies as solid clients and is involved in co-operative partnership with international pharmaceutical companies. Its pharmaceutical business covers development and production of super-generics with drug formulation and delivery technology. We are specialized in micro-encapsulation using fluid bed and OSF formulation. CTCBIO is capable of manufacturing various types of oral dosage forms and has business capabilities starting from formulation development and all the way to commercial production.
South KoreaStand No: 90G66
Dasan Medichem Co., Ltd. is a specialty drug delivery company developing, manufacturing and marketing technically enhanced APIs, semi-formulation products as well as developing custom formulation and manufacturing for insoluble molecules, sustained release (controlled release) pellets, etc. 1. Oral Finished Dosage form business : tablet / pellet / micro-capsulated powder With our own micro-particle coating technology and oral delivery system technology, we furnish product development, technical transfer, and manufacturing. 2. API Chemical Synthesis business With our own non-infringe patent and technically advanced technology for API synthesis, we furnish product development, technical transfer and manufacturing.
South KoreaStand No: 90D34
DONGBANG FTL was originally founded under the name of Dongbang Synthetic Chemical with the objective to become the most renowned and trused company in the active ingredients industry through fair competition. For the past 20 years, we have acquired KGMP certificates in the fields of Finished Drugs, Active Pharmaceutical Ingredients, and Natural Active Ingredients from the relevant authorities, being acknowledged of its renowned status as a company which can product high quality pharmaceutical products.
South KoreaStand No: 90D42
Since 1970, DongKoo Bio&Pharma Co., Ltd has been evolving into a global healthcare leader. DongKoo Bio&Pharma, consolidated with world-class research centers and PIC/s fulfilled GMP facilities, has been No.1 in Korean dermatology prescription market. DongKoo Bio&Pharm is also in vigor expansion of its commercial territories to global markets in the field of generic drugs and contract manufacturing. The company is also growing its influence in stem cell technology, developing world 1st SVF extraction kit (SMART X) and stem cell conditioned media cosmeceutical (CELL BLOOM). With synergy between bio technology (stem cell technology) and pharmaceutical, DongKoo Bio&Pharma pursues a total healthcare solution that contributes in improving people's quality of life
South KoreaStand No: 90G53
DONGWHA PHARM, the first established pharmaceutical company in Korea founded in 1897, has been engaged in development, production, distribution and marketing of ethical drugs including solid dosage formulations and sterile injectables, APIs, over-the-counter drugs, food supplements, healthcare products, and cosmetics. With a goal to become a global hub for drug development, DONGWHA PHARM has been contributing to human health and well-being worldwide through innovative drug discovery, and global commercialization, driven by the state-of-the-art facilities and the research center. DONGWHA Research Institute has provided the foundation for development of high quality medicines and innovative NCE, such as Zabofloxacin. Furthermore, it continues to conduct research and studies for the development of innovative new drug, drug repositioning, botanical drug, and IMD. DONGWHA PHARM has been in the business of good health and wellness across three centuries building up a wide range of quality brands to improve the quality of life. DONGWHA PHARM is...
South KoreaStand No: 90G39
Enzychem Lifesciences Corporation is a Global New Drug Development Venture that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center located in KAIST in Daejeon and its two GMP manufacturing plants in Jecheon, it has since been developing and producing APIs and functional health foods, and developing global new drugs as the leader of the field.
South KoreaStand No: 90D51
EstechPharma Co Ltd manufactures and markets active pharmaceutical ingredients in South Korea. The company offers products under various categories, such as anti-inflammatory, analgesics, muscle relaxant, anti-septic, anti-spasmodics, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, and anti-histamine, as well as products for the treatment of alcoholism, urinary incontinence, etc.
South KoreaStand No: 90D54
With the corporate mission of “Protecting the Precious Human Life from Various Forms of Diseases”, HANLIM has consistently endeavored to improve the health standard of people since its establishment in 1974. And with your warm encouragements, we have grown to become a leading pharmaceutical company in the ethical drug market specialized in Ophthalmic Products in Korea. Since 1993- we have been approved KGMP by KFDA, 2012- we have been selected as “Innovative Pharmaceutical Company” by MOH, 2016- we have been approved PIC/s GMP by KFDA. HANLIM will do its best to provide highly qualified pharmaceutical products for the future.
South KoreaStand No: 90G42
Huons Co., Ltd. is a company specialized in the provision of pharmaceutical products. The Company's products consist of remedies for the circulatory systems, digestive systems, endocrine systems, genitourinary systems, central nervous systems, autonomic nervous systems and respiratory systems, as well as other drugs, such as antibiotics, chemotherapeutics, anticancer drugs, anticoagulants, hemostatics, antihistamine agents, mineral preparations, vitamins and nutrients.
South KoreaStand No: 90D53
With the company`s slogan, 'Respect humanity', 'Promote human's health' and 'Improve welfare', Il-Yang Pharmaceutical Co. has tried its utmost to manufacture superior medicines for the last half a century. In addition, Il-Yang has put forth its strength for the construction of the country with healthy people under the banner of "challenging the limitations of the medical practice and pharmaceutical dispensing for one hundred years". On the basis of the most advanced medical practice and pharmaceutical dispending and a solid business footing in the Korean market, Il-Yang has exported a variety of pharmaceuticals to approximately 30 countries in the world including the USA and Europe, and has opened an era of lacal production, by establishing Yangjoo Il-Yang Pharmaceutical Limited Company in China and manufacturing end-pharmaceuticals.
South KoreaStand No: 90G40
Founded in 1941, Ildong Pharmaceutical Co Ltd has been contributing to healthier and happier lives of mankind for more than 75 years. We've been developing innovative products by utilizing knowledge, know-how that we have piled up. We mainly manufacture Anticancer, Probiotics, Sodium Hyaluronate and Antibiotics in our state-of-the art facility.
South KoreaStand No: 90G35
Good ingredients make good medicine! INIST ST was founded as DONGWOO SYNTECH CO., LTD. in 2000 and ?has been a leader in medical supply ingredients and ingredient ?synthesizing technology development. Based on change, innovation and affection for life, INIST ST started the development of cerebrovascular medicine and has continued by researching and developing excellent quality generic ingredients and base change incrementally modified drugs and is supplying them locally and globally. Based on long-standing trust and skill, we develop not only multiple first generic ingredients, but also innovative new drugs such as heart disease contrast medium and a calcium blockade anti-cancer drug, and now our advanced technology surpasses the high barriers of the global market, and we are leading as a pioneer in the global market, such as exporting more than 15 billion KRW of products to Japan, a medically advanced country.
South KoreaStand No: 90G57
Founded in 1990 as a joint venture company with Nihon (Japan) Kolmar, Kolmar has grown to be the biggest Korean Pharmaceutical contract manufacturer. In 2002, Kolmar Korea extended our business to cover the pharmaceutical business. We provide a specialized production system with total outsourcing service on development and production of pharmaceutical and quasi-drug. Kolmar Korea has provided customized contract manufacturing service with customers who want to outsource their pharmaceutical products, cosmetics and healthcare foods to be more competitive and to develop new formulations feasible in the market.
South KoreaStand No: 90D32
Korea Pharmaceutical Traders Association(KPTA) is a representative organization on exportation and importation of pharmaceuticals and cosmetics. We strive to foster a favourable trading environment for the pharmaceutical industry. KPTA has assisted promoting international trade business that export-related works for Korean pharmaceutical companies and imported Product Administration. Also, KPTA has successfully built close relationship alongside with other related organizations, both domestic and overseas, to support on promoting international trade business and information exchange efforts.
South KoreaStand No: 90F69
We, Korea United Pharm. Inc., specialized in the human healthcare field, have been manufacturing, marketing, and selling pharmaceutical products since 1987. We have a broad range of products from OTC and ETC including about 30 kinds of anti-cancer products. These products are being exported to over 42 countries around the world. we are investing over 10% of annual turnover in R&D and seeking to expand our product portfolio, focusing on development of IMC(Incrementally Modified Drugs) products with less side effects & improved drug compliance. We have brance offices in the Philippines, Myanmar, Vietnam and Indonesia. These worldwide organizations will help to provide high-quality healthcare products and good services promptly to customers. For further information, please visit our website( www.kup.co.kr ) and contact us without hesitation.
South KoreaStand No: 90D31
Korea Pharmaceutical Traders Association (KPTA), a nonprofit organization, was established in 1957. KPTA has contributed to the development of the ex-importing pharmaceutical products through various trade promotion activities, such as trade information, market research services and business matchmaking. KPTA has grown to represent more than 500 members.
South KoreaStand No: 90G63
KPX life science has manufactured API, pharma intermediates and specialty chemical for pharmaceutical/Agrochemical product. As a partner for multinational pharmaceutical companies, we have satisfied customers with services – CMO/CDMO, custom synthesis and process optimization, also with core technologies – phosgenation,hydrogenation. and cGMP complianced quality stystem.
South KoreaStand No: 90D44
Kukje Pharma was established in 1959 with a founding ideology ‘Respect for life principle and customer-first principle to pursue people's healthy and happy life. We consistently focus on R&D investment to our central research laboratory that was established in 1986. One of our major achievements is our outstanding medical technology for ophthalmic diseases, which include macular degeneration and glaucoma. Using our technology, we have developed and researched on new medication as well as known medicines with universities, national research institutes and government branches. Our product line with certified PIC/s GMP is fully equipped with high performance modern technology such as high-quality lyophilizer for producing Antibiotic Injection. Approximately 150 kinds of medicines including ophthalmic products, antibiotics, GI products, CV products, NSAIDs and so on are being produced and sold as of now and, at the same time, we are constantly expanding the CMO business.
South KoreaStand No: 90D41
Kyongbo Pharmaceutical Co Ltd manufactures and sells active pharmaceutical materials in Korea. Its products include ß-lactamase inhibitors, penicillin products, oral cephalosporins, sterile cephalosporins, cephalosporin intermediates, antihyperlipidemic agents, macrolide antibiotics, oral antidiabetics, and other products. Kyongbo Pharmaceutical Co., Ltd. was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd. in March 2002. The company was founded in 1987 and is based in Asan, South Korea.
South KoreaStand No: 90D31
Myungmoon Pharm Co Ltd engages in the manufacture, wholesale, export, import, and sale of pharmaceuticals in South Korea and internationally. The company is also involved in the sale of chemicals; wholesale of non-pharmaceutical products; and health food activities. Its ETC products include anesthetic and anti-diarrheal agents, hormones, antibiotics, narcotics, muscle relaxants, steroids, appetite suppressants, carcinostatis substances, and other preparations; and circulatory, digestive, respiratory, and central nervous system, as well as dermatology/urology, anti-rheumarthritis, anti-osteoarthritis, anti-diabetics, and anti-osteoporosis products. In addition, the company offers OTC products comprising eye nutrition, skin external preparation, digestive system, calcium, cathartic, parasiticide, genitourinary system, anti-gum disease, circulatory solvent, and topical analgesic products; and antinausants, hepatics, cold drugs, anti-allergic agents, health supplements, anti-diarrheal agents, blended juices, multiple vitamins, and eye drops. Myungmoon Pharm Co Ltd was founded in 1983 and is headquartered in Seoul, South Korea.
South KoreaStand No: 90G59
SamChunDang (SCD) Pharm. Co., Ltd. is the leading pharmaceutical company specialized in ophthalmic fields. We have acquired EU GMP certificate for sterile eye drops from UK MHRA. Since establishment in 1943, we have been providing a high quality pharmaceutical product for the purpose of providing healthier and happier lives for everyone. We provide safety and convenience and also offer a wide range of choices with multi-dose, and preservative-free single-dose eye drops. We have been exporting pharmaceutical products to more than 25 overseas countries for more than 20 years and bave been seeking to expand in to the global market with EU GMP certified technology.
South KoreaStand No: 90F52
Samyang has been developing and marketing novel DDS and medical devices. Samyang recently becomes a fully integrated company with R&D, GMP facility for APIs and FDFs (injections, patches). Samyang has been expanding its relationship with partners and is looking to find potential companies that would create a good synergy.
South KoreaStand No: 90D33
Shin Poong Pharm. Co., Ltd is a R&D oriented multinational pharmaceutical company headquartered in Seoul, South Korea, with 7 manufacturing site worldwide with global partners in over 59 countries. Main Focusing Area Cardiovascular CNS Surgical Woundcare Musculoskeletal Anti-infective Product List R&D Pipeline [Marketed] Medicurtain Inj.: Surgical adhesion barrier (Medical device with novel mode of action) Pyramax Tab.: FDC/Malaria (NCE) Pyramax Granule: FDC/Pediatric malaria (NCE) CandeAmlo Tab.: FDC/hypertension (IMD) EzeRosu Tab.: FDC/hyperlipidemia (IMD) [Phase III-IV] Pyramax Tab.: FDC/Malaria (NCE) Pyramax Granule: FDC/Pediatric malaria (NCE) [Phase II] SP-8203: Acute ischemic stroke (NCE) [Phase I] SP-35454: Osteoporosis/fracture healing (NCE) HyalOne™: Osteoarthritis (NME) [Preclinical] SP-8008: Anti-platelet (NCE) SP-8232: Heart failure (NCE) SP-8356: Atherosclerosis (NCE) FreeWink™: Dermal/body filler (NME) Platform Technology Products Hyal Forte Inj. (Pre-filled) - Sodium hyaluronate 20mg/2mL - Viscosupplement for 3 time treatment (Osteoarthritis) - No.1 Sales in Korea Clamoxin Dispersible Tab. 250mg for syrup - Amoxillin sodium 200mg/Potassium clavulanate 50mg -...
South KoreaStand No: 90G37
For more than 50 years, we have specialized in producing and marketing external products; and started exported our products in 1971. Our main products are:-pain relief, wound care, spray and ointment.
South KoreaStand No: 90G68
Established in 1978, Taejoon Pharmaceutical Co., Ltd. (“Taejoon”) is one of the leading specialty pharmaceutical companies in ophthalmology, radiology and gastroenterology with a global presence in the United States, Europe, Africa, and Asia Pacific Region. Taejoon began to look beyond its national boundary in early 2000s. As steps of its globalization, Taejoon built a state-of-the art factory to the standard of cGMP certification in 2005 and became the first ophthalmic product manufacturer in Korea to obtain GMP certification from the EU in 2008. Subsequently, Taejoon started exporting its first product to the EU in 2009. In recent years, Taejoon has expanded into a number of new markets and increased its presence in existing key markets. Currently, Taejoon's products are marketed in 39 countries worldwide through strategic partnerships.
South KoreaStand No: 90G62
Since 1957, Taiguk Pharm Co Ltd has been committed to the production of outstanding pharmaceutical products through product development and strict quality control. We produce and manage over 300 medicines and quasi-drug (sanitary aids). We aim to contribute to health by supplying good quality products all over the world through export activities.
South KoreaStand No: 90D52
We specialise in pharmaceutical raw materials, intermediates and finished products, and also have strong links in many reliable Korean pharmaceutcial companies. We are introducing valuable items to Korean customers and exporting Korean valuable finished products, API. Our main activities are: - exporting various pharmaceutical raw materials and finished products which are produced by Korean GMP-Pharmaceutical industries - importing and/or distribution various pharmaceutical raw materials and intermediates for domestic customers - promotion, evaluation and licensing-in various foreign pharmaceutical brands for Korean pharmaceutical laboratories - galenic form develpments and promotion & distribution of special excipients to Korean pharmaceutical laboratories.
South KoreaStand No: 90G34
YooYoung Pharmaceutical Co., Ltd. places a high value on improving the health of human being and we have achieved sustainable growth and development since its foundation, 1981 and we are dedicated to aim to be the highest level of pharmaceutical manufacturer through the realization of long-term planning.
South KoreaStand No: 90F53
Equipped with state-of-the-art research capabilities and manufacturing facilities compliant with the United States Food and Drug Administration (FDA) current Good Manufacturing Practices (cGMP) regulations, Yuhan is growing into a global pharmaceutical company that offers one-stop custom synthesis services from R&D to commercial production of active pharmaceutical products (APIs) and intermediates. Yuhan has successfully provided high-quality APIs and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.
South KoreaStand No: 90G44
Since its establishment in 1952, Yungjin Pharm. Co., Ltd. has been enjoying the privilege of playing a major role as a forerunner in the Korean pharmaceutical industry for over half a century. Based on our long-term goal, we strive for further growth and expansion. Strong alliance with the worldwide pharmaceutical companies allows us to expand our market into the worldwide and cope with the challenging environment of global pharmaceutical industry. Through active involvement in R&D activities, quality management and overseas business, we will fulfill the expectations of our customers and shareholders.